Literature DB >> 3875631

Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members.

R Halpern, A Davidson, A Lazo, G Solomon, R Lahita, B Diamond.   

Abstract

Sera of 27 members of 3 human kindreds with familial systemic lupus erythematosus (SLE) were examined for expression of a cross-reactive idiotype present on anti-DNA antibodies of SLE patients. By radioimmunoassay, serum samples from 6 of 8 SLE patients and 15 of 19 family members had high-titered reactivity with the antiidiotype, 3I. Isoelectric focusing and Western blot analysis of 3I-reactive bands revealed two patterns of reactivity: either a pattern of bands present at pH 5-7, or bands present at pH 5-7 with additional bands present at pH 7-8.5. Cationic bands were found to correlate with the presence of anti-DNA antibodies, indicating that immunoglobulin charge may be a factor in determining specificity for DNA. Millipore filter analysis revealed anti-DNA antibodies in sera of 4 of 8 SLE patients and 2 of 19 family members without SLE. In 2 additional SLE patients and 2 additional family members, anti-DNA antibodies were revealed when sera were analyzed under conditions that dissociate immune complexes. This study indicates that expression of an idiotype associated with anti-DNA antibodies is significantly increased in relatives of SLE patients and usually occurs in the absence of anti-DNA activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875631      PMCID: PMC423889          DOI: 10.1172/JCI112028

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  The human Ia system.

Authors:  R J Winchester; H G Kunkel
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  A Millipore filter assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus.

Authors:  B Ginsberg; H Keiser
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

Review 4.  Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets.

Authors:  S R Block; J B Winfield; M D Lockshin; W A D'Angelo; C L Christian
Journal:  Am J Med       Date:  1975-10       Impact factor: 4.965

5.  Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates.

Authors:  F Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1980-04

6.  Idiotype restriction in human autoantibodies to DNA in systemic lupus erythematosus.

Authors:  M Zouali; A Eyquem
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

7.  Comparative studies of antilymphocyte, antipolynucleotide, and antiviral antibodies among families of patients with systemic lupus erythematosus.

Authors:  O Folomeeva; V A Nassonova; A S Alekberova; N Talal; R C Williams
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

8.  Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies.

Authors:  M Zanetti; J Rogers; D H Katz
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype.

Authors:  R Halpern; J Schiffenbauer; G Solomon; B Diamond
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

10.  Inheritance of immunoglobulin M rheumatoid-factor idiotypes.

Authors:  J L Pasquali; S Fong; C Tsoukas; J H Vaughan; D A Carson
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more
  19 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Idiotypes and autoimmunity.

Authors:  D K Male
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

3.  Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype.

Authors:  A Manheimer-Lory; J B Katz; M Pillinger; C Ghossein; A Smith; B Diamond
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

4.  Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities.

Authors:  M Monestier; A Manheimer-Lory; B Bellon; C Painter; H Dang; N Talal; M Zanetti; R Schwartz; D Pisetsky; R Kuppers
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

5.  Antiidiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients.

Authors:  N I Abdou; R Suenaga; M Hatfield; M Evans; K M Hassanein
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

6.  Molecular characterization of a somatically mutated anti-DNA antibody bearing two systemic lupus erythematosus-related idiotypes.

Authors:  A Davidson; A Manheimer-Lory; C Aranow; R Peterson; N Hannigan; B Diamond
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 7.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

8.  Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives.

Authors:  H Dang; M Takei; D Isenberg; Y Shoenfeld; R Backimer; J Rauch; N Talal
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

9.  Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations.

Authors:  F Silvestris; P Cafforio; F Dammacco
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Antiidiotypic antibodies to sperm in sera of fertile women that neutralize antisperm antibodies.

Authors:  R K Naz; K Ahmad; A C Menge
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.